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Lipocalins are b-barrel proteins, which share three conservedmotifs in their amino acid sequence. In
this study, we identiﬁed by a peptide mapping approach, a seven-amino acid sequence related to
one of these motifs (motif 2) that modulates cell survival. A synthetic peptide based on an insect
lipocalin displayed cytoprotective activity in serum-deprived endothelial cells and leucocytes. This
activity was dependent on nitric oxide synthase. This sequence was found within several lipocalins,
including apolipoprotein D, retinol binding protein, lipocalin-type prostaglandin D synthase, and
many unknown proteins, suggesting that it is a sequence signature and a lipocalin conserved
property.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Lipocalins are multifunctional proteins recognized as carriers of
small hydrophobic molecules [1]. A common feature is their b-
sheet tertiary structure, consisting of eight antiparallel strands,
which form a calyx with a hydrophobic cavity [2]. Lipocalins do
not have high similarity in amino acid sequence, but most mem-
bers share three characteristic conserved sequence motifs [1,3]. It
has been proposed that these motifs should be responsible for con-
served functional and structural properties among lipocalins, by
playing a role in stabilizing their tertiary structure [3] and by
forming a receptor-binding site [1,4]. However, the exact involve-
ment of motifs on the lipocalin properties has not been proved
experimentally.
Members of the lipocalin family are found in a wide range of
species, with roles in metabolism, coloration, perception, repro-
duction, developmental processes and modulation of immune
and inﬂammatory responses [1,5–7]. These proteins are presentchemical Societies. Published by E
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.M. Chudzinski-Tavassi).in a variety of tissues, organs and ﬂuids, usually in small concentra-
tions [8–12], but their expression levels can be increased depend-
ing on the physiological conditions, developmental and health
states [11–15]. Indeed, lipocalins are biochemical markers of can-
cer, lipid disorders, inﬂammatory, neurodegenerative, liver, kidney
and coronary diseases [16–19].
Lipocalin from an insect of the Lepidoptera Order was also re-
ported to be up-regulated in response to injury, suggesting its role
as a ‘‘protective factor” [20]. Furthermore, several lipocalins from
Lepidoptera have been described [21–23] and are the most abun-
dant components in the bristles of Lonomia obliqua moth caterpil-
lars [24–26]. In this study, we obtained synthetic peptides based
on the three conserved motifs found in the primary sequence of
a lipocalin from L. obliqua (lopap), and thus demonstrate that a
peptide related to one of these motifs is capable to promote cell
survival.2. Materials and methods
2.1. Peptide synthesis
Synthetic peptides were obtained from Organic Peptidic Genetic
Pharmaceutic (ORPEGEN Pharma, Germany). Their amino acid
sequences were based on three conserved motifs in the primary
sequence of the L. obliqua prothrombin activator protease (lopap)lsevier B.V. All rights reserved.
Fig. 2. Motif 2 related peptides protect cells from death. Cell viability measured in
HUVECs after 72 h in RPMI/1% FBS in absence (control) and in presence of each
peptide. Cell viability is shown as percentage of cells in RPMI/10% FBS. Data are
presented as the mean and S.E.M. for triplicate measurements. ***P < 0.001 in
comparison to control.
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the number is related with the correspondent motif.
2.2. Peptide screening and cell viability assays
Human umbilical vein endothelial cells (HUVECs) were ob-
tained and assayed as previously described [27]. Cells (1  104)
were cultured in Roswell Park Memorial Institute 1640 medium
(RPMI) supplemented with 1% fetal bovine serum (FBS), in 96-well
microtiter plates. The cell viability assay based on the reduction of
3-(4,5-dimethylthiazol-2-methyl)-2,5-diphenyltetrazolium bro-
mide (MTT) [28] was performed after 72 h of incubation with the
synthetic peptides (5.0 lg/ml). Cells cultured without serum-de-
prived conditions (RPMI/10% FBS) provided values for positive con-
trol (100% cell viability). The shortest peptide displaying cell death
protection activity was used in subsequent assays.
2.3. Evaluation of nitric oxide synthesis and apoptosis in neutrophils
and endothelial cells
The active peptide was tested in rat neutrophils and microvas-
cular endothelial cells for evaluation of its effect on the generation
of nitric oxide (NO) and cell survival, in the conditions previously
described [29]. The cells (1  106) were simultaneously incubated
with pM2b (3 lg/ml) and Nx-nitro-L-arginine methyl ester
(L-NAME, 1 M) in 1% FBS, and 10 or 20% FBS in the controls of
100% cell viability of neutrophils and endothelial cells, respec-
tively. Levels of NO released by cells were quantiﬁed through the
stable metabolite NO2 in the culture supernatants, by Griess reac-
tion, after 18 h for neutrophils and 48 h for endothelial cells. Cell
viability was evaluated after 24 h by ﬂow cytometry analysis using
FITC annexin V and propidium iodide, to distinguish between
apoptosis and necrosis. Neutrophils were also subjected to acridine
orange and propidium iodide staining, visualized by ﬂuorescence
microscopy.
2.4. Search for conserved domains and structure analysis
The search for conserved motifs related to the sequence of the
active peptides identiﬁed was done at Motif Search Library
(http://motif.genome.jp/). This sequence was also employed for
similarity search using blastp [30], and for conserved domain
search [31]. Lopap 3-D model [21] was employed to analyze the
location of the peptide sequence using Pymol, and was submitted
to structural alignment with the models of purpurin (PURP,
P08938) and prostaglandin D synthase (PGDS-h, P41222), retrieved
from ModBase [32]. Relative surface accessibility (RSA), polarity
and hydropathicity of amino acid residues were compared among
these proteins. For description of these analyses and conserved do-
main search, see Supplementary materials and methods.Fig. 1. Synthetic peptides derived from lipocalin motifs found in lopap primary sequence
in the catalytic triad are in black boxes. The lipocalin motifs are highlighted in the ﬁgur3. Results and discussion
3.1. Motif 2-derived peptides have cytoprotective activity
It has been a challenge to understand the physiological roles of
lipocalins and explain their related properties. Overall data sug-
gests lipocalins acting as physiological regulators and primary host
survival factors, arising some questions. Does each conserved motif
confer common activities to the lipocalins? Could they remain con-
served within a highly diverse sequence by carrying a functional
property? In order to address these questions, we obtained syn-
thetic peptides based on the lipocalin motifs (pM1, pM2a, pM2b
and pM3) found in lopap’s primary sequence (Fig. 1, Supplemen-
tary Table S1). The motif-based peptides were tested on HUVECs
induced to apoptosis by serum deprivation, for assaying their ef-
fects on cell death protection, as previously reported for lopap
[27]. The peptides pM2a and pM2b, which are related to motif 2
and share a sequence of seven-amino acid residues (pM2c), were
able to protect cells from death (Fig. 2).
Lopap was ﬁrstly isolated from the bristles of L. obliqua as a
prothrombin activator [33,34]. It is the ﬁrst described lipocalin
with proteolytic activity, which have a predicted catalytic triad
formed by His168, Glu171 and Ser119 [21]. In addition to its proco-
agulant effect, we have previously demonstrated that lopap dis-
plays antiapoptic activity [27]. The shorter peptide identiﬁed
that retains lopap’s cytoprotective activity (pM2b) does not con-
tain the residues supposedly involved in the catalytic activity of
lopap, thus indicating that both properties are unrelated. Lopap’s
enzymatic activity may be an acquired property resulting from
specialization, as well as for other few lipocalins that show enzy-
matic activities [8,35]. Independent studies have shown other. The peptide sequences are shown in grey or open boxes. The amino acids predicted
e.
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there is debate if cell modulation by lipocalins is mediated by
the protein itself, by their carried ligand, or it is dependent on a
speciﬁc carbohydrate moiety [1,39,40]. Herein, we demonstrated
that the cytoprotective activity is restricted to a short amino acid
sequence. However, it does not provide a deﬁnitive answer to the
question of how lipocalin cell modulation is mediated/regulated,
since post-translational modiﬁcations and ligand binding can
change protein conformation and therefore have the potential to
alter its activity.Fig. 3. Motif 2 related peptide modulates neutrophil and endothelial cell survival depend
in the supernatant of cells cultured in presence of pM2b and/or L-NAME. (C and D) Cell
S.E.M. for triplicate measurements. ***P < 0.001, **P < 0.01 in comparison to control. ##
visualized under ﬂuorescence microscope (400 magniﬁcation) after acridine orange
chromatin condensation (1–6) staining in bright green in the early stages of apoptosis th3.2. pM2b triggers cell survival on neutrophils and endothelial cells via
nitric oxide synthesis
Since we have previously observed that lopap increases NO lev-
els in the supernatant of cell cultures subjected to serum depriva-
tion [27,29], we performed assays on rat neutrophils and
endothelial cells to evaluate the effects of pM2b on NO release
and cell viability, in presence of the NO synthase inhibitor L-NAME.
Treatment with pM2b increased NO levels (Fig. 3A and B) and pro-
moted cell survival (Fig. 3C and D). Both effects were diminishedent on nitric oxide synthase activity. (A and B) Nitric oxide concentration measured
viability in presence of pM2b and/or L-NAME. Data are presented as the mean and
#P < 0.001 in comparison to pM2c treatment. (E) Viable and apoptotic neutrophils
and propidium iodide incorporation assay. Cells undergoing to apoptosis have
at evolutes to orange/red staining, while viable cells have a normal green nucleus.
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ity. The effect of pM2b on cell survival was characterized as an
antiapoptotic activity, since peptide treatment was able to rescue
cells from apoptosis, as also seen by acridine orange/propidium io-
dide staining (Fig. 3E).
3.3. Motif 2 related sequence signature is located at the G–sheet in
antiapoptotic lipocalins
We searched for proteins with sequence similarity to pM2a and
pM2b at public databases using distinct search strategies. The
search for conserved motifs using the sequence comprising both
peptides (pM2ab) at Motif Search Library showed up to 18 groups
of proteins, among them ﬁve groups sharing sequence signatures
related to pM2c (Fig. 4). Blastp aligned pM2c with 103 sequences
of proteins from insects, parasites, fungus, bacteria, archaea and
virus, including outer membrane proteins and many hypothetical
proteins with unknown functions, which showed identities of at
least 80% (Supplementary Table S2). Results obtained from the
search within conserved domains at blast, displayed a number ofFig. 5. Analysis of motif 2 related peptides in the lopap tertiary structure. (A) Lopap struc
in blue. (B) Structural alignment of regions corresponding to pM2a of lopap (green), pros
corresponding to pM2c were represented in lines. (C) Relative hydropathicity, polarity an
tertiary structure, and corresponding peptides of purpurin (P08938) and PGDS-h (P4122
Fig. 4. Alignment of sequence of Lopap-derived peptides with sequence signatures fou
grouping records are shown in brackets.lipocalins showing identities to pM2c at variable hits, including
purpurin, apolipoprotein D, retinol binding protein and prostaglan-
din D synthase (Supplementary Table S3 and Supplementary
Fig. S1).
The location and physical properties of pM2c in the lopap 3-D
model were compared through bioinformatic tools with other anti-
apoptotic lipocalins. pM2c is located in the G-b-sheet [1], and its
conformation closely resembles that of purpurin and prostaglandin
D synthase (Fig. 5A and B). In addition, the curves of relative hyd-
ropathicity, polarity and surface accessibility of each residue com-
posing pM2c embedded in lopap’s tertiary structure were similar
to the corresponding sequences of the antiapoptotic lipocalins
(Fig. 5C). pM2c had a small fraction of its exposed surface poten-
tially accessible to the solvent (Supplementary Table S4), this sur-
face area was mainly visible inside the typical lipocalin b-barrel
(Supplementary Fig. S2). The low rate of RSA of pM2c does not sup-
port its involvement in binding, but conformational changes due to
ligand binding, complex formation and protein cleavage cannot be
ruled out at present. Sequence and structure analyses indicate that
lipocalins share a sequence signature that is directly involved inture model. pM2c is highlighted in green, residues of the predicted catalytic triad are
taglandin D synthase (PGDS-h, gray), purpurin (Purp, rose). Side-chains of residues
d accessible surface (RSA) of residues composing pM2c peptide embedded in lopap’s
2).
nd at Motif Search Library matching with pM2c. Databases and identiﬁcation of
2900 A.M. Chudzinski-Tavassi et al. / FEBS Letters 584 (2010) 2896–2900cytoprotective activity, whose mechanism of action involves mod-
ulation of NO synthesis. However, no molecular target or speciﬁc
interaction has been identiﬁed at the moment. These subjects are
currently under investigation to describe the exact mechanism of
action by which Lopap and derived peptides can modulate cell re-
sponses and promote cell survival. Lipocalins from L. obliqua cater-
pillars can be responsible for cell survival in support of
metamorphosis phenomenon occurring in the caterpillar.
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